ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.37 USD 1.48% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

Balance Sheet

Balance Sheet Decomposition
ATAI Life Sciences NV

Current Assets 117.9m
Cash & Short-Term Investments 88.3m
Receivables 12.1m
Other Current Assets 17.5m
Non-Current Assets 97.9m
Long-Term Investments 93.5m
PP&E 1.9m
Other Non-Current Assets 2.4m
Current Liabilities 17.6m
Accounts Payable 3.8m
Accrued Liabilities 12.8m
Other Current Liabilities 1m
Non-Current Liabilities 30.2m
Long-Term Debt 18.6m
Other Non-Current Liabilities 11.7m

Balance Sheet
ATAI Life Sciences NV

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
30
97
362
191
45
Cash Equivalents
30
97
362
191
45
Short-Term Investments
0
0
0
83
134
Total Receivables
9
1
6
10
2
Other Current Assets
0
1
7
4
4
Total Current Assets
39
100
375
287
186
PP&E Net
0
0
0
1
2
PP&E Gross
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
Note Receivable
0
2
4
7
11
Long-Term Investments
23
8
28
7
92
Other Long-Term Assets
0
2
7
3
3
Total Assets
62
N/A
112
+80%
414
+271%
305
-26%
293
-4%
Liabilities
Accounts Payable
1
3
6
2
5
Accrued Liabilities
1
8
7
15
15
Short-Term Debt
0
0
0
0
0
Other Current Liabilities
0
1
8
2
1
Total Current Liabilities
2
12
21
20
20
Long-Term Debt
0
2
1
15
18
Minority Interest
1
5
9
5
1
Other Liabilities
1
2
7
5
11
Total Liabilities
3
N/A
21
+509%
37
+80%
45
+20%
51
+13%
Equity
Common Stock
7
8
18
19
19
Retained Earnings
20
189
358
510
551
Additional Paid In Capital
73
266
725
774
795
Other Equity
1
6
8
22
19
Total Equity
59
N/A
91
+54%
377
+315%
261
-31%
243
-7%
Total Liabilities & Equity
62
N/A
112
+80%
414
+271%
305
-26%
293
-4%
Shares Outstanding
Common Shares Outstanding
153
153
161
166
166

See Also

Discover More